BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22370779)

  • 21. Methods for iPS cell generation for basic research and clinical applications.
    Mochiduki Y; Okita K
    Biotechnol J; 2012 Jun; 7(6):789-97. PubMed ID: 22378737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.
    Sekine K; Takebe T; Suzuki Y; Kamiya A; Nakauchi H; Taniguchi H
    Transplant Proc; 2012 May; 44(4):1127-9. PubMed ID: 22564643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.
    Mizuno Y; Chang H; Umeda K; Niwa A; Iwasa T; Awaya T; Fukada S; Yamamoto H; Yamanaka S; Nakahata T; Heike T
    FASEB J; 2010 Jul; 24(7):2245-53. PubMed ID: 20181939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current studies on induced pluripotent stem cells in retinal degenerative diseases].
    Zhu JL; Zheng QX; Li WS
    Zhonghua Yan Ke Za Zhi; 2012 Apr; 48(4):374-8. PubMed ID: 22800459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
    Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
    Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.
    Senju S; Haruta M; Matsunaga Y; Fukushima S; Ikeda T; Takahashi K; Okita K; Yamanaka S; Nishimura Y
    Stem Cells; 2009 May; 27(5):1021-31. PubMed ID: 19415766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells.
    Onorati M; Camnasio S; Binetti M; Jung CB; Moretti A; Cattaneo E
    Mol Cell Neurosci; 2010 Mar; 43(3):287-95. PubMed ID: 20026276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
    Nishiyama T; Takeda S
    Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ES and iPS cell research for cardiovascular regeneration.
    Yamashita JK
    Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient hepatic differentiation from human iPS cells by gene transfer.
    Kawabata K; Inamura M; Mizuguchi H
    Methods Mol Biol; 2012; 826():115-24. PubMed ID: 22167644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced adult stem (iAS) cells and induced transit amplifying progenitor (iTAP) cells-a possible alternative to induced pluripotent stem (iPS) cells?
    Heng BC; Richards M; Ge Z; Shu Y
    J Tissue Eng Regen Med; 2010 Feb; 4(2):159-62. PubMed ID: 19967742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iPSC technology: platform for drug discovery. Point.
    Ellis J; Bhatia M
    Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse induced pluripotent stem cells.
    Geoghegan E; Byrnes L
    Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research for cell therapy by induced pluripotent stem cell].
    Sakurai H; Yamanaka S
    Nihon Rinsho; 2011 Dec; 69(12):2114-8. PubMed ID: 22242307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
    Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
    Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.